CNS / Neurology Market
CNS / Neurology Therapeutic Sector
In this section you will find information products, including market insight and company profiles.Stay up-to-date with new products added to this category »
| Title | Publication Date | Price |
|---|---|---|
| Neuroprotection (2 parts) Technologies, Markets and Companies |
January 2012 | £3240 |
| Endpoints - Clinical Trials in CNS Disorders Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted |
November 2011 | £2215 |
| Bipolar Disorder Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
November 2011 | £2215 |
| Central Nervous System Disorders Therapeutics Market to 2017 Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half The Market Value in 2010 |
November 2011 | £2215 |
| Neurodegenerative Disease Market to 2017 Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone Will Restrain Growth |
October 2011 | £2215 |
| Anti-Inflammatory Therapeutics Market to 2017 Respiratory Diseases and Arthritis Continue to Dominate |
October 2011 | £2215 |
| Depression Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
October 2011 | £2215 |
| Eldepryl Analysis and Estimates from 2002 to 2012 |
July 2011 | £1265 |
| Pardoprunox Analysis and Forecasts from 2013 to 2020 |
July 2011 | £1265 |
| Tasmar Analysis and Estimates from 2004 to 2020 |
July 2011 | £1265 |
| Safinamide Analysis and Estimates from 2012 to 2020 |
July 2011 | £1265 |
| Trerief Analysis and Estimates from 2009 to 2020 |
July 2011 | £1265 |
| Preladenant Analysis and Estimates from 2014 to 2020 |
July 2011 | £1265 |
| KW-6002 Analysis and Forecasts from 2013 to 2020 |
July 2011 | £1265 |
| Apokyn Analysis and Estimates from 2004 to 2020 |
July 2011 | £1265 |
| Mirapex ER Analysis and Estimates from 2009 to 2020 |
July 2011 | £1265 |
| Zelapar Analysis and Estimates from 2002 to 2020 |
July 2011 | £1265 |
| Stalevo Analysis and Estimates from 2003 to 2020 |
July 2011 | £1265 |
| Mirapex Analysis and Estimates from 2002 to 2020 |
July 2011 | £1265 |
| Azilect Analysis and Estimates from 2005 to 2020 |
July 2011 | £1265 |
| Comtan Analysis and Estimates from 2002 to 2020 |
July 2011 | £1265 |
| Requip XL Analysis and Estimates from 2007 to 2020 |
July 2011 | £1265 |
| IPX066 Analysis and Estimates from 2013 to 2020 |
July 2011 | £1265 |
| Zicronapine Analysis and Forecasts from 2014 to 2020 |
July 2011 | £1265 |
| Seroquel Analysis and Estimates from 2002 to 2020 |
July 2011 | £1265 |
| Saphris Analysis and Estimates from 2009 to 2020 |
July 2011 | £1265 |
| Cariprazine Analysis and Forecasts from 2013 to 2020 |
July 2011 | £1265 |
| Clozapine Analysis and Forecasts from 2002 to 2020 |
July 2011 | £1265 |
| Geodon Analysis and Forecasts from 2002 to 2017 |
July 2011 | £1265 |
| Zyprexa Analysis and Forecasts from 2002 to 2018 |
July 2011 | £1265 |
